MeiraGTx Executives Show Quiet Confidence: Chief Medical Officer’s Quarterly Vesting Adds to Long‑Term Stake in Gene‑Therapy Pioneer.
MeiraGTx insider activity shows executives buying and selling shares around the market price, indicating confidence in the company’s gene‑therapy pipeline and a cautious optimism for future growth.
4 minutes to read